EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer

Overview of attention for article published in Breast Cancer Research, August 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 10 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 45 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 82,331 followers.

RT @Dr_Ivanoncologo: #EFFECT: a randomized #phaseII study of #efficacy and impact on function of two doses of #nab-paclitaxel as 1L treatme…

Reply Repost Favourite

RT @Dr_Ivanoncologo: #EFFECT: a randomized #phaseII study of #efficacy and impact on function of two doses of #nab-paclitaxel as 1L treatme…

Reply Repost Favourite

RT @Dr_Ivanoncologo: #EFFECT: a randomized #phaseII study of #efficacy and impact on function of two doses of #nab-paclitaxel as 1L treatme…

Reply Repost Favourite

RT @Dr_Ivanoncologo: #EFFECT: a randomized #phaseII study of #efficacy and impact on function of two doses of #nab-paclitaxel as 1L treatme…

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.